000 | 00985 a2200265 4500 | ||
---|---|---|---|
005 | 20250513131505.0 | ||
264 | 0 | _c19971110 | |
008 | 199711s 0 0 eng d | ||
022 | _a0959-4973 | ||
024 | 7 |
_a10.1097/00001813-199708002-00007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVan Cutsem, E | |
245 | 0 | 0 |
_aFuture developments with 'Tomudex' (raltitrexed). _h[electronic resource] |
260 |
_bAnti-cancer drugs _cAug 1997 |
||
300 |
_aS33-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
650 | 0 | 4 |
_aThiophenes _xtherapeutic use |
773 | 0 |
_tAnti-cancer drugs _gvol. 8 Suppl 2 _gp. S33-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001813-199708002-00007 _zAvailable from publisher's website |
999 |
_c9346499 _d9346499 |